Page last updated: 2024-10-25

desipramine and Papilloma

desipramine has been researched along with Papilloma in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Papilloma: A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinjo, T1
Kowalczyk, P1
Kowalczyk, M1
Walaszek, Z1
Nishimaki, T1
Slaga, TJ1
Hanausek, M1

Other Studies

1 other study available for desipramine and Papilloma

ArticleYear
Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription.
    Molecular carcinogenesis, 2009, Volume: 48, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Blotting, Western; Carcinoma, S

2009